MedPath

Monell Chemical Senses Center

🇺🇸United States
Ownership
-
Established
1968-01-01
Employees
-
Market Cap
-
Website
http://www.monell.org

Focused Ultrasound Shows Promise in Alzheimer's Treatment

• A clinical trial using focused ultrasound to treat Alzheimer’s disease has shown promising results, marking a potential new direction in treating this debilitating condition. • The study, published in the Journal of Neurosurgery, highlights the noninvasive nature of focused ultrasound as a key advantage in Alzheimer's treatment. • Researchers are optimistic about the potential of this approach to offer a new therapeutic avenue for patients suffering from Alzheimer's disease. • Further research is needed to fully understand the long-term effects and optimal use of focused ultrasound in Alzheimer's treatment.
© Copyright 2025. All Rights Reserved by MedPath